{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T08:25:56Z","timestamp":1793780756772,"version":"4.6.1"},"reference-count":144,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,6]]},"abstract":"<jats:p>The PREGNANT trial was a randomized, placebo-controlled, multicenter trial designed to determine the efficacy and safety of vaginal progesterone (VP) to reduce the risk of birth <jats:italic toggle=\"yes\">&lt;<\/jats:italic>33 weeks and of neonatal complications in women with a sonographic short cervix (10 to 20 mm) in the mid-trimester (19 to 23 6\/7 wk). Patients allocated to receive VP had a 45% lower rate of preterm birth (8.9% vs 16.1%; relative risk = 0.55; 95% CI: 0.33-0.92). Neonates born to mothers allocated to VP had a 60% reduction in the rate of respiratory distress syndrome. This article reviews the background, design, execution, interpretation, and impact of the PREGNANT Trial.<\/jats:p>","DOI":"10.1097\/grf.0000000000000867","type":"journal-article","created":{"date-parts":[[2024,4,5]],"date-time":"2024-04-05T08:08:06Z","timestamp":1712304486000},"page":"433-457","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":11,"title":["Vaginal Progesterone to Prevent Spontaneous Preterm Birth in Women With a Sonographic Short Cervix: The Story of the PREGNANT Trial"],"prefix":"10.1097","volume":"67","author":[{"given":"Roberto","family":"Romero","sequence":"first","affiliation":[{"name":"Pregnancy Research Branch, Division of Obstetrics and Maternal-Fetal Medicine, Division of Intramural Research, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, United States Department of Health and Human Services, Bethesda, Maryland"},{"name":"Department of Obstetrics and Gynecology, University of Michigan, Ann Arbor, Michigan"},{"name":"Department of Epidemiology and Biostatistics, Michigan State University, East Lansing, Michigan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arun","family":"Meyyazhagan","sequence":"additional","affiliation":[{"name":"Pregnancy Research Branch, Division of Obstetrics and Maternal-Fetal Medicine, Division of Intramural Research, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, United States Department of Health and Human Services, Bethesda, Maryland"},{"name":"Department of Obstetrics and Gynecology, Wayne State University School of Medicine, Detroit, Michigan"},{"name":"Centre of Perinatal and Reproductive Medicine, University of Perugia, Perugia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonia S.","family":"Hassan","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Wayne State University School of Medicine, Detroit, Michigan"},{"name":"Office of Women\u2019s Health, Integrative Biosciences Center, Wayne State University, Detroit, Michigan"},{"name":"Department of Physiology, Wayne State University School of Medicine, Detroit, Michigan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George W.","family":"Creasy","sequence":"additional","affiliation":[{"name":"Center for Biomedical Research, Population Council, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agustin","family":"Conde-Agudelo","sequence":"additional","affiliation":[{"name":"Oxford Maternal and Perinatal Health Institute, Green Templeton College, University of Oxford, Oxford, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2024,4,5]]},"reference":[{"key":"R1-20250512","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1002\/uog.5174","article-title":"Prevention of spontaneous preterm birth: the role of sonographic cervical length in identifying patients who may benefit from progesterone treatment","volume":"30","author":"Romero","year":"2007","journal-title":"Ultrasound Obstet Gynecol"},{"key":"R2-20250512","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1002\/uog.9017","article-title":"Vaginal progesterone reduces the rate of preterm birth in women with a sonographic short cervix: a multicenter, randomized, double-blind, placebo-controlled trial","volume":"38","author":"Hassan","year":"2011","journal-title":"Ultrasound Obstet Gynecol"},{"key":"R3-20250512","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1126\/science.80.2069.190.b","article-title":"Crystalline progestin","volume":"80","author":"Allen","year":"1934","journal-title":"Science"},{"key":"R4-20250512","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1126\/science.82.2120.153.b","article-title":"Nomenclature of corpus luteum hormone","volume":"82","author":"Allen","year":"1935","journal-title":"Science"},{"key":"R5-20250512","first-page":"317","article-title":"Ludwig Fraenkel, corpus luteum and discovery of progesterone","volume":"120","author":"Frobenius","year":"1998","journal-title":"Zentralbl Gynakol"},{"key":"R6-20250512","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1136\/pgmj.45.519.57","article-title":"The luteo-placental shift, the guardian of pre-natal life","volume":"45","author":"Csapo","year":"1969","journal-title":"Postgrad Med J"},{"key":"R7-20250512","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1016\/0002-9378(72)90181-0","article-title":"The significance of the human corpus luteum in pregnancy maintenance. I. Preliminary studies","volume":"112","author":"Csapo","year":"1972","journal-title":"Am J Obstet Gynecol"},{"key":"R8-20250512","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/0002-9378(73)90517-6","article-title":"Effects of luteectomy and progesterone replacement therapy in early pregnant patients","volume":"115","author":"Csapo","year":"1973","journal-title":"Am J Obstet Gynecol"},{"key":"R9-20250512","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/0090-6980(81)90060-5","article-title":"Relationship between timing of ovariectomy and maintenance of pregnancy in the guinea-pig","volume":"22","author":"Csapo","year":"1981","journal-title":"Prostaglandins"},{"key":"R10-20250512","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/0002-9378(71)90242-0","article-title":"Peripheral plasma progesterone levels during human pregnancy and labor","volume":"110","author":"Csapo","year":"1971","journal-title":"Am J Obstet Gynecol"},{"key":"R11-20250512","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/0002-9378(75)90001-0","article-title":"Hormones in human pregnancy. IV. Plasma progesterone","volume":"121","author":"Tulchinsky","year":"1975","journal-title":"Am J Obstet Gynecol"},{"key":"R12-20250512","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/j.ajog.2020.06.004","article-title":"Menstruation: science and society","volume":"223","author":"Critchley","year":"2020","journal-title":"Am J Obstet Gynecol"},{"key":"R13-20250512","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1152\/physrev.00031.2019","article-title":"Physiology of the endometrium and regulation of menstruation","volume":"100","author":"Critchley","year":"2020","journal-title":"Physiol Rev"},{"key":"R14-20250512","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.siny.2006.05.001","article-title":"Inflammation in preterm and term labour and delivery","volume":"11","author":"Romero","year":"2006","journal-title":"Semin Fetal Neonatal Med"},{"key":"R15-20250512","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1055\/s-2006-956773","article-title":"The role of inflammation and infection in preterm birth","volume":"25","author":"Romero","year":"2007","journal-title":"Semin Reprod Med"},{"issue":"12 pt 2","key":"R16-20250512","doi-asserted-by":"crossref","first-page":"S194","DOI":"10.1301\/nr.2007.dec.S194-S202","article-title":"Inflammation in pregnancy: its roles in reproductive physiology, obstetrical complications, and fetal injury","volume":"65","author":"Romero","year":"2007","journal-title":"Nutr Rev"},{"issue":"5 pt 1","key":"R17-20250512","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1016\/0002-9378(89)90172-5","article-title":"Infection and labor. III. Interleukin-1: a signal for the onset of parturition","volume":"160","author":"Romero","year":"1989","journal-title":"Am J Obstet Gynecol"},{"key":"R18-20250512","first-page":"235","article-title":"Amniotic fluid interleukin-1 in spontaneous labor at term","volume":"35","author":"Romero","year":"1990","journal-title":"J Reprod Med"},{"issue":"4 pt 1","key":"R19-20250512","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/0002-9378(91)90422-N","article-title":"Neutrophil attractant\/activating peptide-1\/interleukin-8 in term and preterm parturition","volume":"165","author":"Romero","year":"1991","journal-title":"Am J Obstet Gynecol"},{"key":"R20-20250512","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1016\/0002-9378(93)90297-V","article-title":"Neutrophil attractant\/activating peptide-1\/interleukin-8: association with histologic chorioamnionitis, preterm delivery, and bioactive amniotic fluid leukoattractants","volume":"169","author":"Cherouny","year":"1993","journal-title":"Am J Obstet Gynecol"},{"key":"R21-20250512","doi-asserted-by":"crossref","first-page":"4835","DOI":"10.1096\/fj.14-254383","article-title":"Eicosanomic profiling reveals dominance of the epoxygenase pathway in human amniotic fluid at term in spontaneous labor","volume":"28","author":"Maddipati","year":"2014","journal-title":"FASEB J"},{"key":"R22-20250512","doi-asserted-by":"crossref","first-page":"102195","DOI":"10.1016\/j.plefa.2020.102195","article-title":"Prostaglandin and prostamide concentrations in amniotic fluid of women with spontaneous labor at term with and without clinical chorioamnionitis","volume":"163","author":"Peiris","year":"2020","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"key":"R23-20250512","first-page":"213","article-title":"Matrix metalloproteinases-9 in preterm and term human parturition","volume":"8","author":"Athayde","year":"1999","journal-title":"J Matern Fetal Med"},{"key":"R24-20250512","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1067\/mob.2000.108879","article-title":"Evidence for the participation of interstitial collagenase (matrix metalloproteinase 1) in preterm premature rupture of membranes","volume":"183","author":"Maymon","year":"2000","journal-title":"Am J Obstet Gynecol"},{"key":"R25-20250512","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/S0002-9378(00)99072-0","article-title":"Human neutrophil collagenase (matrix metalloproteinase 8) in parturition, premature rupture of the membranes, and intrauterine infection","volume":"183","author":"Maymon","year":"2000","journal-title":"Am J Obstet Gynecol"},{"key":"R26-20250512","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/S0002-9378(99)70562-4","article-title":"The nuclear transcription factor NF-kappaB mediates interleukin-1beta-induced expression of cyclooxygenase-2 in human myometrial cells","volume":"181","author":"Belt","year":"1999","journal-title":"Am J Obstet Gynecol"},{"key":"R27-20250512","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1093\/molehr\/7.6.581","article-title":"Human labour is associated with nuclear factor-kappaB activity which mediates cyclo-oxygenase-2 expression and is involved with the \u2018functional progesterone withdrawal\u2019","volume":"7","author":"Allport","year":"2001","journal-title":"Mol Hum Reprod"},{"key":"R28-20250512","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1477-7827-8-8","article-title":"Nuclear factor-kappa B localization and function within intrauterine tissues from term and preterm labor and cultured fetal membranes","volume":"8","author":"Vora","year":"2010","journal-title":"Reprod Biol Endocrinol"},{"key":"R29-20250512","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1016\/S0140-6736(72)92759-6","article-title":"Labor: a delayed menstruation?","volume":"2","author":"Gustavii","year":"1972","journal-title":"Lancet"},{"key":"R30-20250512","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1177\/1933719117725830","article-title":"Human parturition: nothing more than a delayed menstruation","volume":"25","author":"Pavlicev","year":"2018","journal-title":"Reprod Sci"},{"key":"R32-20250512","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1210\/jcem-58-4-629","article-title":"Daily hormonal changes in the maternal, fetal, and amniotic fluid compartments before parturition in a primate species","volume":"58","author":"Walsh","year":"1984","journal-title":"J Clin Endocrinol Metab"},{"key":"R33-20250512","first-page":"61","article-title":"Parturition","volume":"8","author":"Challis","year":"1986","journal-title":"Oxf Rev Reprod Biol"},{"key":"R34-20250512","first-page":"514","article-title":"Endocrine and paracrine regulation of birth at term and preterm","volume":"21","author":"Challis","year":"2000","journal-title":"Endocr Rev"},{"key":"R35-20250512","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1159\/000061036","article-title":"The comparative physiology of parturition in mammals","volume":"27","author":"Young","year":"2001","journal-title":"Front Horm Res"},{"key":"R36-20250512","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1113\/eph8602178","article-title":"Overview of current research in parturition","volume":"86","author":"Bernal","year":"2001","journal-title":"Exp Physiol"},{"key":"R37-20250512","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1210\/jc.2007-0077","article-title":"Nuclear progesterone receptors in the human pregnancy myometrium: evidence that parturition involves functional progesterone withdrawal mediated by increased expression of progesterone receptor-A","volume":"92","author":"Merlino","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"issue":"suppl 3","key":"R38-20250512","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/j.1471-0528.2006.01120.x","article-title":"The preterm parturition syndrome","volume":"113","author":"Romero","year":"2006","journal-title":"BJOG"},{"issue":"suppl 2","key":"R39-20250512","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1080\/14767050902860690","article-title":"The preterm parturition syndrome and its implications for understanding the biology, risk assessment, diagnosis, treatment, and prevention of preterm birth","volume":"22","author":"Gotsch","year":"2009","journal-title":"J Matern Fetal Neonatal Med"},{"key":"R40-20250512","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1126\/science.1251816","article-title":"Preterm labor: one syndrome, many causes","volume":"345","author":"Romero","year":"2014","journal-title":"Science"},{"key":"R41-20250512","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.siny.2013.10.004","article-title":"Progesterone to prevent spontaneous preterm birth","volume":"19","author":"Romero","year":"2014","journal-title":"Semin Fetal Neonatal Med"},{"key":"R42-20250512","first-page":"793","article-title":"Induction of labor with mifepristone--a randomized, double-blind study versus placebo","volume":"78","author":"Stenlund","year":"1999","journal-title":"Acta Obstet Gynecol Scand"},{"key":"R43-20250512","first-page":"113","article-title":"The effect of antigestagen ZK 98, 199 on the uterine cervix","volume":"283","author":"Chwalisz","year":"1987","journal-title":"Acta Endocrinol"},{"key":"R44-20250512","first-page":"804","article-title":"The effects of mifepristone on cervical ripening and labor induction in primigravidae","volume":"92","author":"Elliott","year":"1998","journal-title":"Obstet Gynecol"},{"key":"R45-20250512","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/S0301-2115(00)00506-6","article-title":"The effects of mifepristone on uterine sensitivity to oxytocin and on fetal heart rate patterns","volume":"97","author":"Giacalone","year":"2001","journal-title":"EurJ Obstet Gynecol Reprod Biol"},{"key":"R46-20250512","first-page":"623","article-title":"Effects of progesterone on iNOS, COX-2, and collagen expression in the cervix","volume":"54","author":"Marx","year":"2006","journal-title":"J HistochemCytochem"},{"key":"R47-20250512","first-page":"69","article-title":"Dynamics of cervical remodeling during pregnancy and parturition: mechanisms and current concepts","volume":"25","author":"Word","year":"2007","journal-title":"SeminReprodMed"},{"key":"R48-20250512","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1093\/oxfordjournals.humrep.a136909","article-title":"Ripening of the uterine cervix of the guinea-pig after treatment with the progesterone antagonist onapristone (ZK 98.299): an electron microscopic study","volume":"4","author":"Hegele-Hartung","year":"1989","journal-title":"Hum Reprod"},{"key":"R49-20250512","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1093\/humrep\/12.10.2093","article-title":"Cervical ripening in guinea-pigs after a local application of nitric oxide","volume":"12","author":"Chwalisz","year":"1997","journal-title":"Hum Reprod"},{"key":"R50-20250512","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/0002-9378(89)90084-7","article-title":"Progesterone antagonist (RU 486) for cervical dilation, labor induction, and delivery in monkeys: effectiveness in combination with oxytocin","volume":"160","author":"Wolf","year":"1989","journal-title":"Am J Obstet Gynecol"},{"issue":"suppl 1","key":"R51-20250512","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1093\/humrep\/9.suppl_1.131","article-title":"The use of progesterone antagonists for cervical ripening and as an adjunct to labour and delivery","volume":"9","author":"Chwalisz","year":"1994","journal-title":"Hum Reprod"},{"key":"R52-20250512","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/0002-9378(78)90282-X","article-title":"Changes in cervical compliance at parturition independent of uterine activity","volume":"130","author":"Stys","year":"1978","journal-title":"Am J Obstet Gynecol"},{"key":"R53-20250512","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1016\/j.ajog.2006.06.013","article-title":"The use of progestational agents for preterm birth: lessons from a mouse model","volume":"195","author":"Elovitz","year":"2006","journal-title":"Am J Obstet Gynecol"},{"key":"R54-20250512","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1093\/molehr\/gag026","article-title":"The effects of labour and of interleukin 1 beta upon the expression of nuclear factor kappa B related proteins in human amnion","volume":"9","author":"Lee","year":"2003","journal-title":"Mol Hum Reprod"},{"key":"R55-20250512","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.jsbmb.2004.12.027","article-title":"New insights into the molecular endocrinology of parturition","volume":"93","author":"Mendelson","year":"2005","journal-title":"J Steroid Biochem Mol Biol"},{"key":"R56-20250512","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1093\/molehr\/gal067","article-title":"Interleukin-1-induced NF-kappaB recruitment to the oxytocin receptor gene inhibits RNA polymerase II-promoter interactions in cultured human myometrial cells","volume":"12","author":"Soloff","year":"2006","journal-title":"Mol Hum Reprod"},{"key":"R57-20250512","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1095\/biolreprod.106.053439","article-title":"The interleukin 1beta-induced expression of human prostaglandin F2alpha receptor messenger RNA in human myometrial-derived ULTR cells requires the transcription factor, NFkappaB","volume":"75","author":"Zaragoza","year":"2006","journal-title":"Biol Reprod"},{"key":"R58-20250512","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.ejogrb.2006.07.024","article-title":"Changes of nuclear factor kappa B (NF-kappaB), cyclooxygenase-2 (COX-2) and matrix metalloproteinase-9 (MMP-9) in human myometrium before and during term labor","volume":"132","author":"Choi","year":"2007","journal-title":"EurJ Obstet Gynecol Reprod Biol"},{"key":"R59-20250512","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1002\/jcp.20901","article-title":"Role of atypical protein kinase C isozymes and NF-kappaB in IL-1beta-induced expression of cyclooxygenase-2 in human myometrial smooth muscle cells","volume":"210","author":"Duggan","year":"2007","journal-title":"J Cell Physiol"},{"key":"R60-20250512","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1093\/molehr\/gal113","article-title":"Involvement of nuclear factor-kB activation through RhoA\/Rho-kinase pathway in LPS-induced IL-8 production in human cervical stromal cells","volume":"13","author":"Shimizu","year":"2007","journal-title":"Mol Hum Reprod"},{"key":"R61-20250512","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1080\/14767050601128019","article-title":"Impact of progesterone on cytokine-stimulated nuclear factor-kappaB signaling in HeLa cells","volume":"20","author":"Vidaeff","year":"2007","journal-title":"J Matern Fetal Neonatal Med"},{"key":"R62-20250512","doi-asserted-by":"crossref","first-page":"e169","DOI":"10.1371\/journal.pmed.0030169","article-title":"Labor-associated gene expression in the human uterine fundus, lower segment, and cervix","volume":"3","author":"Bukowski","year":"2006","journal-title":"PloS Med"},{"key":"R63-20250512","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/j.placenta.2005.06.003","article-title":"Lipopolysaccharide and TNF-alpha activate the nuclear factor kappa B pathway in the human placental JEG-3 cells","volume":"27","author":"Lappas","year":"2006","journal-title":"Placenta"},{"key":"R64-20250512","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.4049\/jimmunol.178.2.1115","article-title":"PDE4 inhibition prevents preterm delivery induced by an intrauterine inflammation","volume":"178","author":"Schmitz","year":"2007","journal-title":"J Immunol"},{"key":"R65-20250512","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/0140-6736(92)91896-G","article-title":"Choriodecidual production of interleukin-8 and mechanism of parturition","volume":"339","author":"Kelly","year":"1992","journal-title":"Lancet"},{"issue":"3 pt 1","key":"R66-20250512","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/S0002-9378(99)70263-2","article-title":"The action of prostaglandin E2 on the human cervix: stimulation of interleukin 8 and inhibition of secretory leukocyte protease inhibitor","volume":"180","author":"Denison","year":"1999","journal-title":"Am J Obstet Gynecol"},{"issue":"pt 3","key":"R67-20250512","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1042\/bj2750645","article-title":"Hormonal regulation of collagenolysis in uterine cervical fibroblasts. Modulation of synthesis of procollagenase, prostromelysin and tissue inhibitor of metalloproteinases (TIMP) by progesterone and oestradiol-17 beta","volume":"275","author":"Sato","year":"1991","journal-title":"Biochem J"},{"key":"R68-20250512","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1095\/biolreprod56.3.575","article-title":"Hormonal regulation of matrix metalloproteinase 9\/gelatinase B gene expression in rabbit uterine cervical fibroblasts","volume":"56","author":"Imada","year":"1997","journal-title":"Biol Reprod"},{"key":"R69-20250512","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1248\/bpb.25.1223","article-title":"An antiprogesterone, onapristone, enhances the gene expression of promatrix metalloproteinase 3\/prostromelysin-1 in the uterine cervix of pregnant rabbit","volume":"25","author":"Imada","year":"2002","journal-title":"Biol Pharm Bull"},{"key":"R70-20250512","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1016\/0002-9378(92)91619-L","article-title":"Origin of cervical collagenase during parturition","volume":"166","author":"Osmers","year":"1992","journal-title":"Am J Obstet Gynecol"},{"key":"R71-20250512","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1093\/humrep\/13.2.245","article-title":"Nitric oxide as the final metabolic mediator of cervical ripening","volume":"13","author":"Chwalisz","year":"1998","journal-title":"Hum Reprod"},{"key":"R72-20250512","doi-asserted-by":"crossref","first-page":"6217","DOI":"10.1074\/jbc.271.11.6217","article-title":"Negative interaction between the RelA(p65) subunit of NF-kappaB and the progesterone receptor","volume":"271","author":"Kalkhoven","year":"1996","journal-title":"J Biol Chem"},{"key":"R73-20250512","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1159\/000061024","article-title":"Prostaglandins, the fetal membranes and the cervix","volume":"27","author":"Bennett","year":"2001","journal-title":"Front Horm Res"},{"key":"R74-20250512","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1210\/me.2005-0242","article-title":"Up-regulation of the progesterone receptor (PR)-C isoform in laboring myometrium by activation of nuclear factor-kappaB may contribute to the onset of labor through inhibition of PR function","volume":"20","author":"Condon","year":"2006","journal-title":"Mol Endocrinol"},{"key":"R75-20250512","doi-asserted-by":"crossref","first-page":"2724","DOI":"10.1210\/me.2006-0112","article-title":"Progesterone receptor plays a major antiinflammatory role in human myometrial cells by antagonism of nuclear factor-kappaB activation of cyclooxygenase 2 expression","volume":"20","author":"Hardy","year":"2006","journal-title":"Mol Endocrinol"},{"key":"R76-20250512","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/j.steroids.2003.08.003","article-title":"All progestins are not created equal","volume":"68","author":"Stanczyk","year":"2003","journal-title":"Steroids"},{"key":"R77-20250512","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1097\/00042192-200310020-00003","article-title":"Role of progestogen in hormone therapy for postmenopausal women: position statement of the North American Menopause Society","volume":"10","year":"2003","journal-title":"Menopause"},{"key":"R78-20250512","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.maturitas.2008.11.013","article-title":"Classification and pharmacology of progestins","volume":"61","author":"Schindler","year":"2008","journal-title":"Maturitas"},{"key":"R79-20250512","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1210\/er.2012-1008","article-title":"Progestogens used in postmenopausal hormone therapy: differences in their pharmacological properties, intracellular actions, and clinical effects","volume":"34","author":"Stanczyk","year":"2013","journal-title":"Endocr Rev"},{"key":"R80-20250512","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1002\/uog.7338","article-title":"Effect of progesterone on cervical shortening in women at risk for preterm birth: secondary analysis from a multinational, randomized, double-blind, placebo-controlled trial","volume":"34","author":"O\u2019Brien","year":"2009","journal-title":"Ultrasound Obstet Gynecol"},{"key":"R81-20250512","doi-asserted-by":"crossref","first-page":"410 e1","DOI":"10.1016\/j.ajog.2009.07.009","article-title":"The effect of treatment with 17 alpha-hydroxyprogesterone caproate on changes in cervical length over time","volume":"201","author":"Durnwald","year":"2009","journal-title":"Am J Obstet Gynecol"},{"key":"R82-20250512","doi-asserted-by":"crossref","first-page":"223 e1","DOI":"10.1016\/j.ajog.2013.01.020","article-title":"Prevention of preterm birth by progestational agents: what are the molecular mechanisms?","volume":"208","author":"Nold","year":"2013","journal-title":"Am J Obstet Gynecol"},{"key":"R83-20250512","doi-asserted-by":"crossref","first-page":"846 e1","DOI":"10.1016\/j.ajog.2015.08.010","article-title":"Vaginal progesterone, but not 17alpha-hydroxyprogesterone caproate, has antiinflammatory effects at the murine maternal-fetal interface","volume":"213","author":"Furcron","year":"2015","journal-title":"Am J Obstet Gynecol"},{"key":"R84-20250512","first-page":"65","article-title":"Double blind study of an agent to prevent pre-term delivery among women at increased risk","volume":"3","author":"Papiernik","year":"1970","journal-title":"Edition Schering, Serie IV, fiche"},{"key":"R85-20250512","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1111\/j.1471-0528.1989.tb02385.x","article-title":"A meta-analysis of randomized control trials of progestational agents in pregnancy","volume":"96","author":"Goldstein","year":"1989","journal-title":"Br J Obstet Gynaecol"},{"key":"R86-20250512","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/j.1471-0528.1990.tb01740.x","article-title":"Progestogen administration in pregnancy may prevent preterm delivery","volume":"97","author":"Keirse","year":"1990","journal-title":"Br J Obstet Gynaecol"},{"key":"R87-20250512","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1111\/j.1471-0528.1989.tb02386.x","article-title":"Efficacy of progesterone support for pregnancy in women with recurrent miscarriage. A meta-analysis of controlled trials","volume":"96","author":"Daya","year":"1989","journal-title":"BrJ Obstet Gynaecol"},{"key":"R88-20250512","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1067\/mob.2003.41","article-title":"Prophylactic administration of progesterone by vaginal suppository to reduce the incidence of spontaneous preterm birth in women at increased risk: a randomized placebo-controlled double-blind study","volume":"188","author":"da Fonseca","year":"2003","journal-title":"Am J Obstet Gynecol"},{"key":"R89-20250512","doi-asserted-by":"crossref","first-page":"2379","DOI":"10.1056\/NEJMoa035140","article-title":"Prevention of recurrent preterm delivery by 17 alpha-hydroxyprogesterone caproate","volume":"348","author":"Meis","year":"2003","journal-title":"N Eng J Med"},{"key":"R90-20250512","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1002\/uog.5158","article-title":"Progesterone vaginal gel for the reduction of recurrent preterm birth: primary results from a randomized, double-blind, placebo-controlled trial","volume":"30","author":"O\u2019Brien","year":"2007","journal-title":"Ultrasound Obstet Gynecol"},{"key":"R91-20250512","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1056\/NEJMoa067815","article-title":"Progesterone and the risk of preterm birth among women with a short cervix","volume":"357","author":"Fonseca","year":"2007","journal-title":"N Engl J Med"},{"key":"R92-20250512","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1002\/uog.5159","article-title":"Vaginal progesterone is associated with a decrease in risk for early preterm birth and improved neonatal outcome in women with a short cervix: a secondary analysis from a randomized, double-blind, placebo-controlled trial","volume":"30","author":"DeFranco","year":"2007","journal-title":"Ultrasound Obstet Gynecol"},{"key":"R93-20250512","first-page":"231","article-title":"International conference on harmonisation of technical requirements for registration of pharmaceuticals for human use (ICH) adopts consolidated guideline on good clinical practice in the conduct of clinical trials on medicinal products for human use","volume":"48","year":"1997","journal-title":"Int Dig Health Legis"},{"key":"R94-20250512","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1080\/105294199277860","article-title":"The International Conference on Harmonization Good Clinical Practice guideline","volume":"6","author":"Dixon","year":"1998","journal-title":"Qual Assur"},{"key":"R95-20250512","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/j.placenta.2013.04.014","article-title":"Chronic chorioamnionitis is the most common placental lesion in late preterm birth","volume":"34","author":"Lee","year":"2013","journal-title":"Placenta"},{"issue":"suppl 4","key":"R96-20250512","doi-asserted-by":"crossref","first-page":"S53","DOI":"10.1016\/j.ajog.2015.08.041","article-title":"Chronic inflammation of the placenta: definition, classification, pathogenesis, and clinical significance","volume":"213","author":"Kim","year":"2015","journal-title":"Am J Obstet Gynecol"},{"key":"R97-20250512","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1056\/NEJMoa067815","article-title":"Progesterone and the risk of preterm birth among women with a short cervix","volume":"357","author":"Fonseca","year":"2007","journal-title":"N Eng J Med"},{"key":"R98-20250512","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1056\/NEJM199602293340904","article-title":"The length of the cervix and the risk of spontaneous premature delivery. National Institute of Child Health and Human Development Maternal Fetal Medicine Unit Network","volume":"334","author":"Iams","year":"1996","journal-title":"N Eng J Med"},{"key":"R99-20250512","doi-asserted-by":"crossref","first-page":"446 e1","DOI":"10.1016\/j.ajog.2010.05.040","article-title":"The risk of impending preterm delivery in asymptomatic patients with a nonmeasurable cervical length in the second trimester","volume":"203","author":"Vaisbuch","year":"2010","journal-title":"Am J Obstet Gynecol"},{"key":"R100-20250512","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1046\/j.1469-0705.1998.12050312.x","article-title":"Cervical length at 23 weeks of gestation: prediction of spontaneous preterm delivery","volume":"12","author":"Heath","year":"1998","journal-title":"Ultrasound Obstet Gynecol"},{"key":"R101-20250512","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1046\/j.1469-0705.1998.12050304.x","article-title":"Cervical length at 23 weeks of gestation: relation to demographic characteristics and previous obstetric history","volume":"12","author":"Heath","year":"1998","journal-title":"Ultrasound Obstet Gynecol"},{"key":"R102-20250512","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1067\/mob.2000.106851","article-title":"Patients with an ultrasonographic cervical length < or =15 mm have nearly a 50% risk of early spontaneous preterm delivery","volume":"182","author":"Hassan","year":"2000","journal-title":"Am J Obstet Gynecol"},{"key":"R104-20250512","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1056\/NEJMra1510065","article-title":"Interpreting geographic variations in results of randomized, controlled trials","volume":"375","author":"Yusuf","year":"2016","journal-title":"N Engl J Med"},{"key":"R105-20250512","first-page":"349","article-title":"Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2. ISIS-2 (Second International Study of Infarct Survival) Collaborative Group","volume":"2","year":"1988","journal-title":"Lancet"},{"key":"R106-20250512","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1542\/peds.50.4.515","article-title":"A controlled trial of antepartum glucocorticoid treatment for prevention of the respiratory distress syndrome in premature infants","volume":"50","author":"Liggins","year":"1972","journal-title":"Pediatrics"},{"key":"R107-20250512","first-page":"186","article-title":"Antenatal glucocorticoid therapy for the prevention of respiratory distress syndrome in the premature infant","volume":"50","author":"Block","year":"1977","journal-title":"Obstet Gynecol"},{"key":"R108-20250512","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/0002-9378(78)90408-8","article-title":"Injection of corticosteroids into mother to prevent neonatal respiratory distress syndrome","volume":"131","author":"Morrison","year":"1978","journal-title":"Am J Obstet Gynecol"},{"key":"R109-20250512","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1542\/peds.63.1.73","article-title":"The antenatal use of betamethasone in the prevention of respiratory distress syndrome: a controlled double-blind study","volume":"63","author":"Papageorgiou","year":"1979","journal-title":"Pediatrics"},{"key":"R110-20250512","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1542\/peds.63.1.64","article-title":"Risk of respiratory distress syndrome after prenatal dexamethasone treatment","volume":"63","author":"Taeusch","year":"1979","journal-title":"Pediatrics"},{"key":"R111-20250512","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/0002-9378(80)90855-8","article-title":"Results of a double-blind controlled study on the use of betamethasone in the prevention of respiratory distress syndrome","volume":"136","author":"Doran","year":"1980","journal-title":"Am J Obstet Gynecol"},{"key":"R112-20250512","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1111\/j.1471-0528.1980.tb04505.x","article-title":"The influence of betamethasone and orciprenaline on the incidence of respiratory distress syndrome in the newborn after preterm labour","volume":"87","author":"Schutte","year":"1980","journal-title":"Br J Obstet Gynaecol"},{"issue":"4 pt 1","key":"R113-20250512","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1203\/00006450-198004000-00013","article-title":"Maternal glucocorticoid in unplanned premature labor. Controlled study on the effects of betamethasone phosphate on the phospholipids of the gastric aspirate and on the adrenal cortical function of the newborn infant","volume":"14","author":"Teramo","year":"1980","journal-title":"Pediatr Res"},{"key":"R114-20250512","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/S0002-9378(84)80172-6","article-title":"Effect of antepartum glucocorticoid administration upon neonatal respiratory distress syndrome and perinatal infection","volume":"148","author":"Schmidt","year":"1984","journal-title":"Am J Obstet Gynecol"},{"key":"R115-20250512","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1111\/j.1471-0528.1989.tb02413.x","article-title":"Antenatal administration of betamethasone to prevent respiratory distress syndrome in preterm infants: report of a UK multicentre trial","volume":"96","author":"Gamsu","year":"1989","journal-title":"Br J Obstet Gynaecol"},{"issue":"5 pt 1","key":"R116-20250512","first-page":"721","article-title":"Use of ampicillin and corticosteroids in premature rupture of membranes: a randomized study","volume":"73","author":"Morales","year":"1989","journal-title":"Obstet Gynecol"},{"key":"R117-20250512","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/0002-9378(91)91193-Z","article-title":"Pharmacologic pulmonary maturation in preterm premature rupture of membranes","volume":"164","author":"Carlan","year":"1991","journal-title":"Am J Obstet Gynecol"},{"key":"R118-20250512","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/0002-9378(92)91691-3","article-title":"A randomized, placebo-controlled trial of betamethasone for the prevention of respiratory distress syndrome at 24 to 28 weeks\u2019 gestation","volume":"166","author":"Garite","year":"1992","journal-title":"Am J Obstet Gynecol"},{"key":"R119-20250512","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1001\/archpedi.1993.02160260077026","article-title":"The effect of antenatal dexamethasone administration on the fetal and neonatal ductus arteriosus. A randomized double-blind study","volume":"147","author":"Eronen","year":"1993","journal-title":"Am J Dis Child"},{"key":"R120-20250512","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/S0002-9378(16)32633-3","article-title":"Effect of antenatal dexamethasone administration on the prevention of respiratory distress syndrome","volume":"141","year":"1981","journal-title":"Am J Obstet Gynecol"},{"key":"R121-20250512","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/0002-9378(95)90222-8","article-title":"Antenatal corticosteroid therapy: a meta-analysis of the randomized trials, 1972 to 1994","volume":"173","author":"Crowley","year":"1995","journal-title":"Am J Obstet Gynecol"},{"key":"R122-20250512","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1001\/jama.1995.03520290065031","article-title":"Effect of corticosteroids for fetal maturation on perinatal outcomes. NIH consensus development panel on the effect of corticosteroids for fetal maturation on perinatal outcomes","volume":"273","year":"1995","journal-title":"JAMA"},{"key":"R124-20250512","doi-asserted-by":"crossref","first-page":"124 e1","DOI":"10.1016\/j.ajog.2011.12.003","article-title":"Vaginal progesterone in women with an asymptomatic sonographic short cervix in the mid-trimester decreases preterm delivery and neonatal morbidity: a systematic review and meta-analysis of individual patient data","volume":"206","author":"Romero","year":"2012","journal-title":"Am J Obstet Gynecol"},{"key":"R125-20250512","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1515\/jpm-2022-0462","article-title":"Vaginal progesterone for the prevention of preterm birth: who can benefit and who cannot? Evidence-based recommendations for clinical use","volume":"51","author":"Conde-Agudelo","year":"2023","journal-title":"J Perinat Med"},{"key":"R126-20250512","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.ajog.2015.09.102","article-title":"Vaginal progesterone to prevent preterm birth in pregnant women with a sonographic short cervix: clinical and public health implications","volume":"214","author":"Conde-Agudelo","year":"2016","journal-title":"Am J Obstet Gynecol"},{"key":"R127-20250512","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1002\/uog.8911","article-title":"Universal cervical-length screening to prevent preterm birth: a cost-effectiveness analysis","volume":"38","author":"Werner","year":"2011","journal-title":"Ultrasound Obstet Gynecol"},{"key":"R128-20250512","doi-asserted-by":"crossref","first-page":"100 e1","DOI":"10.1016\/j.ajog.2016.01.192","article-title":"Cost-effectiveness of risk-based screening for cervical length to prevent preterm birth","volume":"215","author":"Einerson","year":"2016","journal-title":"Am J Obstet Gynecol"},{"key":"R129-20250512","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1111\/aogs.13021","article-title":"Is routine transvaginal cervical length measurement cost-effective in a population where the risk of spontaneous preterm birth is low?","volume":"95","author":"Crosby","year":"2016","journal-title":"Acta Obstet Gynecol Scand"},{"key":"R130-20250512","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1007\/s40273-014-0133-2","article-title":"Cost and cost effectiveness of vaginal progesterone gel in reducing preterm birth: an economic analysis of the PREGNANT trial","volume":"32","author":"Pizzi","year":"2014","journal-title":"Pharmacoeconomics"},{"key":"R131-20250512","doi-asserted-by":"crossref","first-page":"548 e1","DOI":"10.1016\/j.ajog.2009.12.005","article-title":"Universal cervical length screening and treatment with vaginal progesterone to prevent preterm birth: a decision and economic analysis","volume":"202","author":"Cahill","year":"2010","journal-title":"Am J Obstet Gynecol"},{"key":"R132-20250512","doi-asserted-by":"crossref","first-page":"S66","DOI":"10.1016\/j.ajog.2012.10.291","article-title":"126: The impact of cervical length on the cost-effectiveness of vaginal progesterone as a preterm birth intervention","volume":"208","author":"Page","year":"2013","journal-title":"Am J Obstet Gynecol"},{"key":"R133-20250512","doi-asserted-by":"crossref","first-page":"S201","DOI":"10.1016\/j.ajog.2013.10.430","article-title":"397: Cost analysis of universal cervical length screening and progesterone therapy in remote populations","volume":"210","author":"Brown","year":"2014","journal-title":"Am J Obstet Gynecol"},{"key":"R134-20250512","doi-asserted-by":"crossref","first-page":"A510","DOI":"10.1016\/j.jval.2014.08.1565","article-title":"Cervical assessment with progesterone in the prevention of preterm birth: a strategy based on cost-effectiveness","volume":"17","author":"Fonseca","year":"2014","journal-title":"Value Health"},{"key":"R135-20250512","doi-asserted-by":"crossref","first-page":"S367","DOI":"10.1016\/j.ajog.2014.10.962","article-title":"756: Vaginal progesterone versus cervical cerclage for the prevention of preterm births in women with a sonographically short cervix&#x2013;a cost effectiveness and decision analysis","volume":"212","author":"Eke","year":"2015","journal-title":"Am J Obstet Gynecol"},{"key":"R136-20250512","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1016\/j.ajog.2016.11.903","article-title":"13: Implementation of universal cervical length screening is associated with a reduction in the rate of spontaneous preterm delivery in a low-risk cohort","volume":"216","author":"Green","year":"2017","journal-title":"Am J Obstet Gynecol"},{"key":"R137-20250512","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.ajog.2011.12.008","article-title":"Vaginal progesterone for asymptomatic cervical shortening and the case for universal screening of cervical length","volume":"206","author":"Combs","year":"2012","journal-title":"Am J Obstet Gynecol"},{"key":"R138-20250512","first-page":"318","article-title":"Principles and practice of screening for disease","volume":"16","author":"Wilson","year":"1968","journal-title":"J R Coll Gen Pract"},{"key":"R139-20250512","doi-asserted-by":"crossref","first-page":"603 e1","DOI":"10.1016\/j.ajog.2015.12.017","article-title":"Universal cervical length screening in singleton gestations without a previous preterm birth: ten reasons why it should be implemented","volume":"214","author":"Khalifeh","year":"2016","journal-title":"Am J Obstet Gynecol"},{"key":"R140-20250512","doi-asserted-by":"crossref","first-page":"365 e1","DOI":"10.1016\/j.ajog.2015.12.020","article-title":"A universal mid-trimester transvaginal cervical length screening program and its associated reduced preterm birth rate","volume":"214","author":"Son","year":"2016","journal-title":"Am J Obstet Gynecol"},{"key":"R141-20250512","doi-asserted-by":"crossref","first-page":"523 e1","DOI":"10.1016\/j.ajog.2016.02.002","article-title":"Universal cervical length screening: implementation and outcomes","volume":"214","author":"Temming","year":"2016","journal-title":"Am J Obstet Gynecol"},{"key":"R142-20250512","doi-asserted-by":"crossref","first-page":"219 e1","DOI":"10.1016\/j.ajog.2022.07.046","article-title":"The introduction of a universal transvaginal cervical length screening program is associated with a reduced preterm birth rate","volume":"228","author":"Figarella","year":"2023","journal-title":"Am J Obstet Gynecol"},{"key":"R143-20250512","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.ajog.2017.11.576","article-title":"Vaginal progesterone for preventing preterm birth and adverse perinatal outcomes in singleton gestations with a short cervix: a meta-analysis of individual patient data","volume":"218","author":"Romero","year":"2018","journal-title":"Am J Obstet Gynecol"},{"key":"R144-20250512","doi-asserted-by":"crossref","first-page":"e0245746","DOI":"10.1371\/journal.pone.0245746","article-title":"Cervical length varies considering different populations and gestational outcomes: results from a systematic review and meta-analysis","volume":"16","author":"Bortoletto","year":"2021","journal-title":"PLoS ONE"},{"key":"R145-20250512","first-page":"513","article-title":"Screening for cancer: evaluating the evidence","volume":"63","author":"Gates","year":"2001","journal-title":"Am Fam Physician"},{"key":"R146-20250512","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1200\/JCO.2010.30.6373","article-title":"What is the true number needed to screen and treat to save a life with prostate-specific antigen testing?","volume":"29","author":"Loeb","year":"2011","journal-title":"J Clin Oncol"},{"key":"R147-20250512","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.ajog.2013.04.027","article-title":"Progesterone is not the same as 17alpha-hydroxyprogesterone caproate: implications for obstetrical practice","volume":"208","author":"Romero","year":"2013","journal-title":"Am J Obstet Gynecol"}],"container-title":["Clinical Obstetrics &amp; Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/GRF.0000000000000867","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,12]],"date-time":"2025-05-12T15:16:28Z","timestamp":1747062988000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/GRF.0000000000000867"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,5]]},"references-count":144,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/grf.0000000000000867","relation":{},"ISSN":["0009-9201"],"issn-type":[{"value":"0009-9201","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4,5]]}}}